IMPROVING PATIENT’S QUALITY OF LIFE USING A CERAMIDE CONTAINING MOISTURISER AS MONOTHERAPY IN MILD TO MODERATE ATOPIC DERMATITIS
New Efficacy results on the use of Effaclar Serum in adjunct to Clascoterone 1% in mild to moderate acne
FIP World Congress 2026 - Basic guidance and role of community pharmacists in acne vulgaris management | L'Oréal Dermatological Beauty
Basic guidance and role of community pharmacists in managing drug-related photosensitivity - FIP World Congress 2026 | L'Oréal Dermatological Beauty
Basic guidance and role of community pharmacists in skin cancer prevention and photoprotection counseling - FIP World Congress 2026 | L'Oréal Dermatological Beauty
Basic guidance and role of community pharmacists in managing cancer treatment induced skin reactions - FIP World Congress 2026 | L'Oréal Dermatological Beauty
Basic guidance and role of community pharmacists in managing atopic dermatitis - FIP World Congress 2026 | L'Oréal Dermatological Beauty
Basic guidance and role of community pharmacists in management of superficial wounds and scar prevention - FIP World Congress 2026 | L'Oréal Dermatological Beauty
Enhanced Efficacy of Post-Procedural Skin Care: A Double-Blind, Randomized, Vehicle-Controlled, Split-Face Clinical Study Assessing a Novel Neuropeptide Serum Following Botulinum Toxin Injection
EVALUATING A NOVEL, INVISIBLE SUNSCREEN WITH MCE FILTER AND 2 -MNG ACTIVE FOR ENHANCED PROTECTION AGAINST HEVL -INDUCED PIGMENTATION
EFFICACY AND TOLERABILITY OF A 2-MNG-CONTAINING SERUM IN THE TREATMENT OF FACIAL SOLAR ENTIGO OVER 3 MONTHSOF DAILY APPLICATIONS